Vicore Pharma Holding AB (publ) has appointed the Nomination Committee for the 2022 Annual General Meeting. The three largest shareholders as of August 31, 2021 have been offered to appoint a member to the Nomination Committee each, in accordance with the decision taken at the Annual General Meeting on May 11, 2021. The Nomination Committee consists of Staffan Lindstrand, appointed by HealthCap VII L.P., Ulrik Grönvall appointed by Swedbank Robur and Jannis Kitsakis, appointed by Fourth Swedish National Pension Fund. Vicore Pharma's chairman, Michael Wolff Jensen, is also a member and acts as the convener of the Nomination Committee.